Close
Nordic 9Nordic 9

Ysios Capital (investor - Private Equity)

Spain ysioscapital.com
See something wrong or missing? Let us know
Offices:Barcelona, San Sebastian

Ysios Capital is an independent venture capital firm from Spain that provides private equity financing to early- and mid-stage human healthcare and life science companies and targeting the biotechnology industry, with an exclusive focus on therapeutics.

Average round investment:56.69M USD
Average number per year:2.9
Distribution: 2025 (2)2024 (3)2023 (5)2022 (1)2021 (4) See the entire list
Portfolio companies: Spain Splice BioSwitzerland ReproNovoDenmark Adcendo See the entire list
Mostly invests in: Denmark Denmark (7) Health services (22)
See the entire list

Showing 3 of 22 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Ysios Capital mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ysios Capital

Name Criteria
United States M12
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: Denmark, France
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United States BoxGroup
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Spain, France
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
France AG2R LA MONDIALE
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Germany Bastian Nominacher
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, France
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
France Groupe ADP
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Norway Hadean Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Denmark, Netherlands, Spain, France
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Malta Apeiron Investment Group
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Switzerland, France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United States Menlo Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, Switzerland
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Belgium SFPI-FPIM
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Netherlands, France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
France Safran Corporate Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Top